Clinical Trial Update: Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating a single-dose liposomal amphotericin B regimen for visceral leishmaniasis, sponsored by Banaras Hindu University. The c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Visceral Leishmaniasis

Drugs mentioned

• AMBISOME (AMPHOTERICIN B)

Snippet

Sponsor: Banaras Hindu University | Conditions: Visceral Leishmaniasis | Phase 4 | Status: UNKNOWN